Autoimmune liver disease: novelties in management

Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):273-6. doi: 10.1016/j.clinre.2014.03.015. Epub 2014 Apr 22.

Abstract

Autoimmune liver disease is the second commonest cause of chronic liver disease in teenagers. There are several forms including autoimmune hepatitis, autoimmune sclerosing cholangitis, primary sclerosing cholangitis and various overlap syndromes, classified on the basis of different serum antibody profiles, histological features and appearances on cholangiography. Treatment with immunosupressants is usually effective, but often required medium to long-term, raising concerns about side effects and adherence to therapy. For a minority of children presenting in acute liver failure or with difficult-to-treat disease liver transplantation is a possible option, although risk of recurrence in the grafted liver remains lifelong.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibodies / blood
  • Autoimmune Diseases / diagnosis*
  • Autoimmune Diseases / drug therapy
  • Cholangiography
  • Cholangiopancreatography, Magnetic Resonance
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Diseases / diagnosis*
  • Liver Diseases / drug therapy
  • Liver Diseases / immunology*
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antibodies
  • Glucocorticoids
  • Immunosuppressive Agents
  • Vancomycin